Systemic release of thrombomodulin, but not from the cardioplegic, reperfused heart during open heart surgery

Thrombosis Research

Volumn 83, Issue 4, 1996, Pages 321-328

  Valen, Guro ^a   Sigurdardottir, Olöf ^a   Vaage, Jarle ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiac surgery; Cardioplegia; Endothelial injury; Ischemia reperfusion; Thrombomodulin

Indexed keywords

HEPARIN; THROMBOMODULIN;

ARTICLE; CARDIOPLEGIA; CLINICAL ARTICLE; ENDOTHELIUM CELL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; OPEN HEART SURGERY; PRIORITY JOURNAL; REPERFUSION;

EID: 0030586887     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00140-5     Document Type: Article

References (40)

1. BOLLI, R. Postischemic myocardial "stunning": Pathogenesis, pathophysiology, and clinical relevance. In: Myocardial protection. The pathophysiology of reperfusion injury. D.M. Yellon, R.B. Jennings (eds), pp. 105-150, Raven Press, New York (1992).
2. CASTHELY P.A., MEKHIJAN H., YOGANATHAN. Cardiovascular complications following open heart surgery. In: Cardiopulmonary bypass: physiology, related complications, and pharmacology. P.A. Casthely, D. Bregman (eds.), pp. 299-330, Futura Publishing Company, New York (1991).
3. LINDAHL S., SÖRLIE D., JÖRGENSEN L. Endothelial cells of the cardiac microvasculatur during and after cold cardioplegic ischemia. Comparison of endothelial and myocyte damage. Scand J Thor Cardiovasc Surg. 22:1988;257-265.
4. VAAGE J., VALEN G. Pathophysiology and mediators of ischemia-reperfusion injury with special reference to cardiac surgery. Scand J Thor Cardiovasc Surg. 41(suppl):1993;1-18.
5. ZILLA P., VON OPPELL U., DEUTSCH M. The endothelium: A key to the future. J Card Surg. 8:1993;32-60.
6. KIRKLIN J.W., BARRAT-BOYES B.G. Cardiac Surgery. Wiley, New York (1993).
7. VAAGE J., VALEN G. Could treatment with oxygen radical scavengers minimize complications in cardiac surgery? Klin Wochenschr. 69:1991;1066-1072.
8. KATUS H.A., SCHOPPENTHAU M., TANZEEM A., BAUER H.G., SAGGAU W., DIEDERICH K.W., HAGL S., KUEBLER W. Non-invasive assessment of perioperative myocardial cell damage by circulating cardiac Troponin-T. Br Heart J. 65:1991;259-264.
9. MAIR J., DIENSTL F., PUSCHENDORF B. Cardiac Troponin-T and the diagnosis of cardiac injury. Crit Rev Clin Lab Sci. 29:1992;31-57.
10. DINERMAN J.L., MEHTA J.L. Endothelial, platelet and leukocyte interactions in ischemic heart disease: Insights into potential mechanisms and their clinical relevance. J Am Coll Cardiol. 16:1990;207-222.
11. VALEN G. The search for markers of endothelial injury during cardiac surgery. Eur J Cardiothorac Surg. 10:1996;297-298.
12. VALEN G., ERIKSSON E., RISBERG B., VAAGE J. Fibrinolysis during cardiac surgery: Release of tissue plasminogen activator in arterial and coronary sinus blood. Eur J Cardio-thorac Surg. 8:1994;324-330.
13. VALEN G., BLOMBÄCK M., SELLEI P., LINDBLOM D., VAAGE J. Open heart surgery increases the level of von Willebrand Factor in arterial blood, but not in the coronary sinus. Thromb Res. 73:1994;21-29.
14. WINNERKVIST A., WIMAN B., VALEN G., VAAGE J. There is no dose-dependency between release of tissue plasminogen activator and oxidative stress in isolated, perfused rat hearts. Thromb Res, in press, 1996.
15. BOFFA M.C., KAROCHKINE M., BERARD M. Plasma thrombomodulin as a marker of endothelium damage. Nouv Rev Fr Hematol. 33:1991;529-530.
16. ESMON N.L. Thrombomodulin. In: Progress in hemostasis and thrombosis. B.S. Coller (ed.), pp 29-55, WB Saunders Co, Philadelphia (1989).
17. SEIGNEUR M., DUFOURCQ P., CONRI C., CONSTANS J., MERCIE P., PRUVOST A., BOISSEAU M.R. Plasma thrombomodulin; new approach of endothelial damage. Int Angiol. 12:1993;355-359.
18. ISHII H., UCHIYAMA H., KAZAMA M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haem. 65:1991;618-623.
19. SAWADA K., YAMAMOTO H., YAGO H., SUEHIRO S. A simple assay to detect endothelial cell injury: measurement of released thrombomodulin from cells. Exp Mol Pathol. 57:1992;116-123.
20. TAKAHASHI H., ITO S., HANANO M., WADA K., NIWANO H., SEKI Y., SHIBATA A. Circulating thrombomodulin as a novel endothelial cell marker: Comparison of its behaviour with von Willebrand Factor and tissue-type plasminogen activator. Am J Hematol. 41:1992;32-39.
21. AMIRAL J., ADAM M., MIMILLA F., LARRIVAZ I., CHAMBRETTE B., BOFFA M.C. A new assay for soluble forms of thrombomodulin in plasma. Thromb Haem. 65:1991;947.
22. AMIRAL J., ADAM M., MIMILLA F., LARRIVAZ I., CHAMBRETTE B., BOFFA M.C. Design and validation of a new immunoassay for soluble forms of thrombomodulin and studies on plasma. Hybridoma. 13:1994;205.
23. CAVAROCCHI N.C., ENGLAND M.D., SCHAFF H.V., RUSSO P., ORZULAK T.A., SCHNELL W.A., O'BRIEN J.F., PLUTH J.R. Oxygen free radical generation during cardiopulmonary bypass: Correlation with complement activation. Circulation. 74:1986;III130-III133.
24. KHARAZMI A., ANDERSEN L.W., BAEK L., VALERIUS N.H., LAUB M., RASMUSSEN J.P. Endotoxemia and enhanced generation of oxygen radicals by neutrophils from patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 98:1989;381-385.
25. DAVIES S.W., DUFFY J.P., WICKENS D.G., UNDERWOOD S.M., HILL A., ALLADINE F., FENECK R.O., DORMANDY T.L., WALESBY R.K. Time-course of free radical activity during coronary artery bypass operations with cardiopulmonary bypass. J Thorac Cardiovasc Surg. 105:1993;979-987.
26. ROYSTON D., FLEMING J.S., DESAI J.B., WESTABY S., TAYLOR K.M. Increased production of peroxidation products associated with cardiac operations. J Thorac Cardiovasc Surg. 91:1986;759-766.
27. SMITH E.E.J., NAFTEL D.C., BLACKSTONE E.H., KIRKLIN J.W. Microvascular permeability after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 94:1987;225-233.
28. TANAKA K., TAKAO M., YADA I., YUASA H., KUSAGAWA M., DEGUCHI K. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. J Cardiothorac Anesth. 3:1989;181-188.
29. 2 during coronary revascularization. J Thorac Cardiovasc Surg. 9:1987;120-126.
30. JONES D.K., LUDDINGTON R., HIGENBOTTAM T.W., SCOTT J., CAVAROCCHI N., REARDON D., CALVIN J., WALLWORK J. Changes in factor VIII proteins after cardiopulmonary bypass in man suggest endothelial damage. Thromb Haem. 60:1988;199-204.
31. GANDO S., TEDO I., MASIO H., GODA Y., KAWAGASHI H. Increased fibrinolytic activity during cardiopulmonary bypass is caused by activated protein C system. Japan J Anesth. 43:1994;912-914.
32. JOURNOIS D., MAURIAT P., POUARD P., MARCHOT P., AMIRAL J., SAFRAN D. Assessment of coagulation factor activation during cardiopulmonary bypass with a new monoclonal antibody. J Cardiothorac Vasc Anesth. 8:1994;157-161.
33. BOLDT J., SCHINDLER E., WELETERS I., WITTSTOCK M., STERMANN W.A., HEMPELMANN G. The effect of the anticoagulation regimen on endothelial-related coagulation in cardiac surgical patients. Anaesthesia. 50:1995;954-960.
34. SEMB A.G., VAAGE J., SÖRLIE D., LIE M., MJÖS O.D. Coronary trapping of a complement activation product (C3a des-Arg) during myocardial reperfusion in open-heart surgery. Scand J thor Cardiovasc Surg. 24:1990;223-227.
35. SEMB A.G., FORSDAHL K., VAAGE J. Granulocyte and eicosanoid gradients across the coronary circulation during myocardial reperfusion in cardiac surgery. Eur J Cardio-thorac Surg. 4:1990;543-548.
36. TORTOLANI A.J., POWELL S.R., MISIK V., WEGLICKI W.B., POGO G.J., KRAMER J.H. Detection of alkoxyl and carbon-centered free radicals in coronary sinus blood from patients undergoing elective cardioplegia. Free Radic Biol Med. 14:1993;421-426.
37. MICKLE D., WIESEL R.D., BURTON G.W., INGOLD K.U. Effect of orally administered alpha-tocopherol acetate on human myocardial alpha-tocopherol levels. Cardiovasc Drugs Ther. 5:1991;309-312.
38. WEISEL R.D., MICKLE D.A.G., FINCKLE C.D., TUMIATI L.C., MADONIK M.M., IVANOV J., BURTON G.W., INGOLD K.U. Myocardial free-radical injury after cardioplegia. Circulation. 80:1989;III14-III18.
39. SIXMA J.J., DE GROOT P.G. von Willebrand Factor and the blood vessel wall. Mayo Clin Proc. 66:1991;628-633.
40. WU K.K. Endothelial cells in hemostasis, thrombosis, and inflammation. Hospital Practice. 15:1992;145-166.